# Colgate-Palmolive (India) Ltd. - Comprehensive Data Collection Report
**Analysis Date:** February 10, 2026
**Ticker:** COLPAL | **Exchange:** NSE
**Current Price:** ₹2,183 | **Market Cap:** ₹58,629.22 Crores

---

## EXECUTIVE SUMMARY

Colgate-Palmolive (India) Limited is a mature FMCG company in the personal care segment with exceptional operational metrics but challenging growth dynamics. The stock is currently **OVERVALUED** at 30% premium to intrinsic fair value, trading with limited upside despite strong fundamentals.

### Investment Thesis: SELL / AVOID

**Suitable For:**
- Dividend income investors willing to accept a 25-30% price correction
- Conservative value investors seeking entry at ₹1,600-1,700

**Not Suitable For:**
- Growth investors seeking capital appreciation
- Momentum traders (negative trend momentum)
- Risk-averse investors (valuation premium presents downside risk)

---

## PHASE 1: FUNDAMENTALS & VALUATION

### Current Market Metrics (as of Feb 10, 2026)

| Metric | Value | Percentile |
|--------|-------|-----------|
| **Current Price** | ₹2,183 | |
| **52-Week High** | ₹2,747.40 | +25.8% above current |
| **52-Week Low** | ₹2,029.40 | -7.0% below current |
| **Market Cap** | ₹58,629.22 Cr | |
| **P/E Ratio** | 40.81 | **27% above sector avg (32)** |
| **P/B Ratio** | 35.22 | **Very high for stable company** |
| **Dividend Yield** | 2.37% | Attractive for income investors |
| **Price Position in Range** | 21.4% | Weak (near 52-week low) |

### Financial Health Scorecard

| Component | Score | Assessment | Key Metrics |
|-----------|-------|-----------|-----------|
| **Profitability** | 9/10 | Exceptional | ROE 81.2%, ROCE 105%, Op Margin 30%+ |
| **Growth** | 6/10 | Moderate | Revenue CAGR 6%, Profit CAGR 10% (5yr) |
| **Balance Sheet** | 9.5/10 | Excellent | D/E 0.037, Nearly debt-free, Strong cash |
| **Cash Flow** | 9/10 | Excellent | OCF/NP 0.97, FCF ₹1,323 Cr, High quality |
| **Quality** | 9/10 | Outstanding | Negative WC cycle, High earning quality |
| **Overall Health** | 8.4/10 | Very Strong | — |

---

## VALUATION ANALYSIS

### Fair Value Estimates (Multiple Methodologies)

| Methodology | Fair Value | Weight | Rationale |
|-------------|-----------|--------|-----------|
| **PE-Based** | ₹1,718 | 30% | Sector PE 32x + 10% growth premium = 35.2x |
| **Graham Number** | ₹1,841 | 20% | Conservative value floor: sqrt(22.5 × EPS × Book Value) |
| **DCF Simplified** | ₹696 | 20% | Conservative FCF multiple approach; likely undervalued |
| **EV/EBITDA** | ₹2,250 | 30% | Sector 32x multiple applied to ₹1,897 Cr EBITDA |
| **BLENDED FAIR VALUE** | **₹1,676** | — | Weighted average across methods |

### Valuation Verdict

```
Current Price:           ₹2,183
Blended Fair Value:      ₹1,676
Upside/(Downside):       -30.3%
Margin of Safety:        Missing (trading at 30% premium)
```

**Assessment:** Stock is **OVERVALUED** by approximately ₹500-600 per share. Even the highest fair value estimate (EV/EBITDA ₹2,250) suggests limited upside. PEG ratio of 4.46 further confirms overvaluation relative to 10% earnings growth.

---

## FINANCIAL PERFORMANCE DEEP DIVE

### Quarterly Trend Analysis (Last 8 Quarters)

| Quarter | Sales (Cr) | Net Profit (Cr) | EPS | Op Margin | Revenue Growth YoY | Profit Growth YoY |
|---------|-----------|-----------------|-----|-----------|-------------------|------------------|
| **Q3 FY26** | 1,486 | 324 | 11.91 | 30.0% | -1.6% | +0.3% |
| **Q2 FY26** | 1,457 | 395 | 14.51 | 29.0% | +1.3% | +8.2% |
| **Q1 FY26** | 1,404 | 355 | 13.04 | 30.2% | +2.1% | +4.6% |
| **Q4 FY25** | 1,672 | 366 | 13.46 | 31.2% | +4.2% | +14.3% |

**Key Observations:**
- Q3 FY26 shows concerning profit decline despite revenue stability
- Operating margins remain stable (29-31%) but under pressure from regulatory costs
- Revenue growth has decelerated from +4.2% (Q4) to -1.6% (Q3)
- Profit growth now flat/negative after quarters of double-digit gains

### Annual Growth Metrics (5-Year View)

| Period | Revenue (Cr) | Net Profit (Cr) | EPS | Growth Rates |
|--------|-------------|-----------------|-----|-------------|
| **FY25** | 6,040 | 1,437 | 52.83 | — |
| **FY24** | 5,696 | 1,305 | 47.95 | Rev: +6.0%, NP: +10.1% |
| **FY23** | 5,360 | 1,185 | 43.57 | Rev: +5.9%, NP: +10.2% |

**5-Year CAGR:**
- Revenue CAGR: 6.0% (mature market growth)
- Profit CAGR: 10.0% (operational leverage from mix and cost control)
- EPS CAGR: 11.8% (helped by share buybacks)

---

## BALANCE SHEET & CASH FLOW STRENGTH

### Balance Sheet Highlights

| Item | FY25 | Assessment |
|------|------|-----------|
| **Total Assets** | ₹3,019 Cr | Efficient asset utilization |
| **Total Equity** | ₹1,664 Cr | Strong retained earnings base |
| **Total Debt** | ₹61 Cr | **Almost debt-free** |
| **Debt-to-Equity** | 0.037 | Exceptional (industry avg 0.3-0.5) |
| **Interest Coverage** | Extremely Strong | Minimal debt burden |

### Cash Flow Quality

| Metric | FY25 | Assessment |
|--------|------|-----------|
| **Operating Cash Flow** | ₹1,394 Cr | — |
| **Net Profit** | ₹1,437 Cr | — |
| **OCF/NP Ratio** | 0.97 | Exceptional (>0.9 indicates high quality) |
| **Free Cash Flow** | ₹1,323 Cr | Strong underlying cash generation |
| **FCF Yield** | 2.26% | Reasonable for mature company |
| **Working Capital Cycle** | -95 days | **Negative = customers pay before paying suppliers** |

**Key Insight:** Negative working capital cycle is a hallmark of efficient cash conversion. Company essentially gets free working capital financing.

---

## SHAREHOLDING PATTERN (December 2025)

| Category | Holding % |
|----------|----------|
| **Promoters** | 51.00% |
| **Domestic Institutions** | 13.79% |
| **Foreign Institutions** | 15.18% |
| **Mutual Funds** | 6.11% |
| **Retail & Others** | 20.04% |

**Assessment:** Promoter-led company with institutional investor confidence. No red flags regarding promoter pledges or governance issues.

---

## PHASE 2: NEWS & SENTIMENT ANALYSIS

### Recent News Summary (Last 30 Days)

**Total News Items Analyzed:** 8
**Aggregate News Sentiment Score:** +0.125 (Neutral-to-Slightly-Positive)
**News Sentiment Label:** NEUTRAL

#### Key News Events

1. **Q3 FY26 Results** (Jan 29, 2026) — EARNINGS
   - Profit flat YoY at ₹323.9 Cr despite 1.7% revenue growth
   - Earnings impact from GST reclassification and new labour code charges
   - Sentiment: Neutral (Impact: HIGH)

2. **Gross Margin Expansion** (Jan 29, 2026) — EARNINGS POSITIVE
   - Gross margin improved to 69.7%, up 50 bps QoQ
   - Demonstrates operational efficiency and favorable product mix shift
   - Sentiment: Positive (Impact: HIGH)

3. **Management Commentary** (Jan 29, 2026) — MANAGEMENT
   - MD Prabha Narasimhan highlighted return to growth with premium segment strength
   - Early positive signs in core portfolio, strong performance in both urban and rural
   - Sentiment: Positive (Impact: MEDIUM)

4. **Dividend Declaration** (Jan 29, 2026) — DIVIDEND
   - First interim dividend of ₹24 per share for FY25-26
   - Total payout ₹652.8 Cr, maintaining consistent dividend policy
   - Sentiment: Positive (Impact: MEDIUM)

5. **Analyst Downgrades**
   - **BofA** (Feb 5): Cut target to ₹2,930 (from higher levels)
   - **Goldman Sachs** (Feb 2): Target ₹2,300 (+5% from current)
   - **Consensus** (Feb 4): 40% Hold rating, wide range ₹2,175-₹3,000
   - Sentiment: Mixed-to-Negative (Impact: MEDIUM)

6. **SEBI Compliance** (Jan 1, 2026) — REGULATORY
   - Depository compliance certificate confirmed; no adverse findings
   - Sentiment: Neutral (Impact: LOW)

### Red Flags Assessment

**Overall Status:** ✓ NO RED FLAGS DETECTED

- No SEBI actions or penalties
- No auditor concerns or qualifications
- No promoter pledges flagged in recent filings
- No legal proceedings against company
- No credit rating downgrades
- Full regulatory compliance maintained

### Upcoming Catalysts (High Impact)

| Event | Expected Date | Impact | Key Significance |
|-------|---------------|--------|-----------------|
| **Q4 FY26 Results** | May 30, 2026 | HIGH | Full-year announcement; FY27 guidance critical for valuation reset |
| **AGM FY26** | June 15, 2026 | MEDIUM | Final dividend announcement, board elections, strategic updates |
| **Q1 FY27 Results** | Aug 1, 2026 | HIGH | First quarter of new fiscal; assess growth momentum sustainability |

---

## PHASE 3: SENTIMENT & TECHNICAL ANALYSIS

### Overall Sentiment Breakdown

```
Market Sentiment:        BEARISH (-0.35)
Fundamental Sentiment:   NEGATIVE (-0.25)
Social Sentiment:        UNAVAILABLE (StockTwits API blocked)
News Sentiment:          NEUTRAL (+0.125)
─────────────────────────────────────
Blended Sentiment:       BEARISH (-0.18)
Confidence Score:        65/100
```

**Confidence Reduction Factors:**
- StockTwits API blocked (403 Forbidden) — limits retail sentiment data
- Reduced by -40 points due to missing social media sentiment

### Market Sentiment Rationale

- Stock down 15.35% YoY despite strong financial fundamentals
- Price in lower 21% of 52-week range (₹2,029-₹2,747 band)
- Market repricing stock lower on growth concerns despite stable operations
- Retail investors showing skepticism about company's 6% revenue CAGR growth potential

### Technical Analysis Summary

| Indicator | Reading | Interpretation |
|-----------|---------|-----------------|
| **Trend** | Downtrend | Moderate strength, persistent weakness |
| **RSI (14)** | 58.86 | Neutral (not overbought, not oversold) |
| **Price Position** | 21.4% of range | In lower third, lacking momentum |
| **Volume Signal** | Normal/Declining | Moderate activity on downtrend |

### Support & Resistance Levels

```
Resistance 2:  ₹2,326.60 (Secondary resistance; trend reversal needed)
Resistance 1:  ₹2,254.80 (First resistance level)
───────────────────────────────────────────────────
CURRENT PRICE: ₹2,183.00
───────────────────────────────────────────────────
Support 1:     ₹2,111.20 (Near-term support)
Support 2:     ₹2,039.40 (Critical support near 52-week low)
```

### Technical Trading Setup

**Recommended Entry:** ₹2,050 (pullback to support on weakness)
**Stop Loss:** ₹2,000 (below critical support)
**Risk/Reward:** -8.4% risk to catch potential +10-25% upside to ₹2,400-₹2,747

**Technical Verdict:** **SELL / AVOID** in near term. Better entry opportunities exist below ₹2,050 or after clear trend reversal signal.

---

## SECTOR CONTEXT & COMPETITIVE POSITIONING

### FMCG - Personal Care Sector Benchmarking

| Metric | COLPAL | Sector Avg | Comparison |
|--------|--------|-----------|-----------|
| **P/E Ratio** | 40.81 | 32.00 | +27% premium |
| **ROE** | 81.2% | 35.0% | +132% above average |
| **ROCE** | 105.0% | 45-50% | +110% above average |
| **Growth (Revenue CAGR)** | 6.0% | 8-10% | Below sector growth |
| **Dividend Yield** | 2.37% | 1.5-2.0% | Attractive |

**Positioning:** COLPAL trades at a significant valuation premium to peers, justified only by superior ROE/ROCE. However, mature growth profile (6% CAGR) doesn't support continued premium valuation.

---

## COMPREHENSIVE INVESTMENT RECOMMENDATION

### Overall Rating: **SELL / REDUCE EXPOSURE**

#### Rating Summary

| Dimension | Rating | Rationale |
|-----------|--------|-----------|
| **Financial Health** | 8.4/10 | Exceptional; nearly debt-free, high profitability, strong cash flow |
| **Growth Prospects** | 4/10 | Muted 6% revenue growth; mature market; limited catalysts |
| **Valuation** | 3/10 | 30% overvalued vs. intrinsic value; unattractive risk/reward |
| **Sentiment** | 3/10 | Bearish market sentiment, analyst downgrades, weak momentum |
| **Technical** | 3/10 | Downtrend, no bullish setup, support under pressure |
| **Income Appeal** | 7/10 | 2.37% dividend yield attractive for conservative investors |

#### Suitability Analysis

**SUITABLE FOR:**
- ✓ Conservative dividend income investors
- ✓ Value investors willing to wait for 25-30% correction
- ✓ Long-term buy-and-hold investors focused on stability
- ✓ Entry points at ₹1,600-1,700 with margin of safety

**NOT SUITABLE FOR:**
- ✗ Growth investors seeking capital appreciation
- ✗ Momentum traders (negative trend momentum)
- ✗ Short-term traders (range-bound trading environment)
- ✗ Risk-averse investors (valuation gap presents downside risk)
- ✗ Current price levels for new accumulation

#### Target Prices

| Horizon | Target Price | Upside/(Downside) | Catalyst |
|---------|-------------|------------------|----------|
| **6 Months** | ₹1,900 | -13.0% | Earnings disappointment, sector underperformance |
| **12 Months** | ₹1,650 | -24.5% | Fair value with margin of safety |
| **Upside Case** | ₹2,400 | +10.0% | Major growth inflection, sector rally |

#### Action Items for Investors

1. **Current Holders (at ₹2,183+):**
   - REDUCE exposure / TAKE PROFITS
   - Maintain dividend-yielding positions for income
   - Consider trimming 25-30% of holdings above ₹2,200

2. **Potential Buyers:**
   - WAIT for pullback to ₹2,050 or below
   - Accumulate only at ₹1,600-1,700 for value investing
   - Consider dividend yields at lower prices (3%+ at ₹1,700)

3. **Dividend Investors:**
   - Monitor Q4 FY26 results (May 30, 2026)
   - Watch for dividend sustainability signals
   - FY27 dividend announcement critical in June AGM

---

## DATA COLLECTION COMPLETENESS

### Sources & Data Quality

| Data Source | Status | Quality | Notes |
|------------|--------|---------|-------|
| **Tickertape Fundamentals** | ✓ Complete | High | All key metrics extracted and validated |
| **StockTwits Sentiment** | ✗ Unavailable | N/A | API blocked (403 Forbidden); attempted multiple ticker formats |
| **Screener.in Financials** | ✓ Complete | High | Comprehensive quarterly and annual data extracted |
| **News & Events** | ✓ Complete | High | 8 news items from Jan 29 - Feb 5, 2026 |
| **Technical Analysis** | ✓ Complete | High | Support/resistance levels, trend analysis calculated |

### JSON Data Files Generated

1. **colgate-palmolive_tickertape.json** (1.0 KB)
   - Current market metrics, shareholding, price performance

2. **colgate-palmolive_stocktwits.json** (665 B)
   - Error documentation (API blocked); alternative sentiment sourced

3. **colgate-palmolive_financials.json** (7.6 KB)
   - Comprehensive financial analysis, valuation models, forecasts

4. **colgate-palmolive_news.json** (8.5 KB)
   - News items, analyst ratings, catalysts, red flags assessment

5. **colgate-palmolive_sentiment.json** (4.7 KB)
   - Blended sentiment analysis, confidence scoring

6. **colgate-palmolive_technical.json** (6.6 KB)
   - Technical indicators, support/resistance, entry/exit strategies

**Total Data Collected:** 28.4 KB | **All JSON files validated:** ✓ PASSED

---

## FINAL VERDICT

**Colgate-Palmolive (India) Limited is a fundamentally sound company with exceptional operational metrics, but the stock is significantly overvalued at current price levels. The combination of:**

1. **Mature growth profile** (6% revenue CAGR)
2. **Elevated valuation multiples** (PE 40.8x, PB 35.2x)
3. **Recent profit stagnation** (Q3 profit flat YoY)
4. **Bearish market sentiment** (down 15% YoY despite fundamentals)
5. **Analyst downgrades** (BofA, consensus mixed)

**...creates an unfavorable risk/reward profile at ₹2,183.**

### Recommended Action: **SELL / AVOID / WAIT FOR CORRECTION**

The stock is suitable only for dividend income investors at significantly lower prices (₹1,600-1,700) where the margin of safety justifies the investment. Current buyers should reassess their conviction on 6% growth delivering the 40x valuation multiples commanded today.

---

**Report Generated:** February 10, 2026
**Data Quality:** High (3 of 4 primary sources complete)
**Next Review:** Post Q4 FY26 results (May 30, 2026)

